Literature DB >> 32189311

Physiological Roles of the von Willebrand Factor-Factor VIII Interaction.

Klytaimnistra Kiouptsi1, Christoph Reinhardt2,3.   

Abstract

Von Willebrand factor (VWF) and coagulation factor VIII (FVIII) circulate as a complex in plasma and have a major role in the hemostatic system. VWF has a dual role in hemostasis. It promotes platelet adhesion by anchoring the platelets to the subendothelial matrix of damaged vessels and it protects FVIII from proteolytic degradation. Moreover, VWF is an acute phase protein that has multiple roles in vascular inflammation and is massively secreted from Weibel-Palade bodies upon endothelial cell activation. Activated FVIII on the other hand, together with coagulation factor IX forms the tenase complex, an essential feature of the propagation phase of coagulation on the surface of activated platelets. VWF deficiency, either quantitative or qualitative, results in von Willebrand disease (VWD), the most common bleeding disorder. The deficiency of FVIII is responsible for Hemophilia A, an X-linked bleeding disorder. Here, we provide an overview on the role of the VWF-FVIII interaction in vascular physiology.

Entities:  

Keywords:  Acute phase protein; Coagulation factor VIII (FVIII); Hemophilia; Hemostasis; Platelet; von Willebrand factor (VWF)

Mesh:

Substances:

Year:  2020        PMID: 32189311     DOI: 10.1007/978-3-030-41769-7_18

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  5 in total

1.  Haemostatic differences between SARS-CoV-2 PCR-positive and negative patients at the time of hospital admission.

Authors:  B de Laat; M J M Traets; R W M De Laat-Kremers; S P Verweij; M Ninivaggi; E Jong; D Huskens; B A Blok; G C P Remme; A Miszta; R H T Nijhuis; G J M Herder; R Fijnheer; M Roest; A T L Fiolet; J A Remijn
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.752

Review 2.  Links between thrombosis and inflammation in traumatic brain injury.

Authors:  W Brad Hubbard; Jing-Fei Dong; Miguel A Cruz; Rolando E Rumbaut
Journal:  Thromb Res       Date:  2020-11-25       Impact factor: 3.944

3.  Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII.

Authors:  Melanie Demers; Maria M Aleman; Elena Kistanova; Robert Peters; Joe Salas; Ekta Seth Chhabra
Journal:  J Thromb Haemost       Date:  2022-05-22       Impact factor: 16.036

4.  The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial.

Authors:  Katarina D Kovacevic; Jürgen Grafeneder; Christian Schörgenhofer; Georg Gelbenegger; Gloria Gager; Christa Firbas; Peter Quehenberger; Petra Jilma-Stohlawetz; Andrea Bileck; Shuhao Zhu; James C Gilbert; Martin Beliveau; Bernd Jilma; Ulla Derhaschnig
Journal:  Haematologica       Date:  2022-09-01       Impact factor: 11.047

Review 5.  Endothelial Dysfunction in Pregnancy Complications.

Authors:  Jakub Kornacki; Paweł Gutaj; Anastasia Kalantarova; Rafał Sibiak; Maurycy Jankowski; Ewa Wender-Ozegowska
Journal:  Biomedicines       Date:  2021-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.